0001209191-20-023673.txt : 20200406
0001209191-20-023673.hdr.sgml : 20200406
20200406200854
ACCESSION NUMBER: 0001209191-20-023673
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200402
FILED AS OF DATE: 20200406
DATE AS OF CHANGE: 20200406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liang Hong
CENTRAL INDEX KEY: 0001754627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38682
FILM NUMBER: 20778150
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kodiak Sciences Inc.
CENTRAL INDEX KEY: 0001468748
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270476525
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 650-281-0850
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: Oligasis, LLC
DATE OF NAME CHANGE: 20090721
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-02
1
0001468748
Kodiak Sciences Inc.
KOD
0001754627
Liang Hong
2631 HANOVER ST.
PALO ALTO
CA
94304
0
1
0
0
SVP, Discovery Medicine
Common Stock
2020-04-02
4
S
0
4000
42.34
D
130166
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.97 to $42.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Carlton Fleming, Attorney-in-fact for Hong Liang
2020-04-06